SPDR World Ex Us

Team Union Criticizes Nestle's Anti-Worker Behavior and Demands End

HSBC's Long Position in Tianqi Lithium H Shares Rises to 28.06%

Barclays Analyst Maintains Nestlé Holding Rating with Target Price of 86 Swiss Francs

Nestle India Expects 13-18% Revenue Growth in Q4 of FY2026

Roche Launches Phase III Study for Elevidys in Response to EMA Feedback

HSBC Continues Commitment to Middle East Investment

HSBC Completes TDS Pilot on Canton Network

Roche Holdings AG to Release FY2026 Q1 Earnings on April 23 Pre-Market EST, Forecast Revenue USD 18.6 B

HSBC Obtains Stablecoin License and Plans to Issue Stablecoins in Hong Kong in the Second Half of the Year

HSBC Appoints Jo Miyake As Interim Head of Europe and Americas

Japanese Health Ministry Approves Myriad MyChoice for Prostate Cancer Companion Diagnostics

HSBC CEO Expresses Long-Term Optimism for China Strategy and Hong Kong Market Development

BNP Paribas Downgrades HSBC ADS to Neutral

HSBC Chairman Nizamuddin Analyzes Inflation and Conflict Impact on Economy and Central Bank Responses

HSBC CEO Worries About Mideast Conflict Dampening Client Confidence

HSBC Chairman Nelson Pessimistic but Optimistic about Global Economy and Hong Kong Market Prospects

HSBC Completes Tokenized Deposit Service Pilot on Canton Network

Dubai Economy and Tourism Ministry Signs Strategic Agreement with HSBC

Morgan Stanley Raises HSBC's Target Price to 1420 Pence

Hong Kong Announces First Stablecoin Issuers License List HSBC and Anchorpoint Financial Obtain License

Energy Focus

DirectBooking Tech

Tradr 2X Long CRML Daily ETF

Leverage Shares 2X Long CRML Daily ETF

CO2 ENERGY TRANSITION CORP. COM USD0.0001 15/10/2028 (SUB/RIGHTS)

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

U Power

YXT.COM

Psyence Biomedical

Critical Metals

NSRGF

NSRGY

FTXG

The Teamsters, led by Jesse Case, criticize Nestlé for anti-worker practices, claiming the company engages in union-busting tactics in the U.S. while promoting a pro-worker image globally. They accuse Nestlé of undermining workers' rights to organize and call for an end to these activities, demanding true neutrality and card check recognition. The Teamsters warn that continued hypocrisy will lead to coordinated actions against Nestlé.

prnewswire

Nestlé S.A.

Nestlé

VG Consumer Stap

First Trust NASDAQ Food & Beverage

Invesco Food & Beverage ETF

iShares US Consumer Staples ETF

SPDR FD Consumer Staples

10:55 ETTEAMSTERS STATEMENT ON NESTLÉ'S ANTI-WORKER AGENDA

HSBA

00005

HSBC

HSBH

HSBC says Q1 earnings remain resilient despite turbulent markets

businessinsider

HSBC Holdings Plc

HSBC HOLDINGS

HSBC Holdings plc ADRhedged

HSBC says Q1 earnings remain resilient despite turbulent markets

Dubai Financial Market (DFM) recently participated in the HSBC Global Investment Summit in Hong Kong, enhancing its international investor engagement. The visit attracted significant interest from Asian institutional investors, emphasizing Dubai's role in global capital allocation. DFM held meetings with investors to discuss market access and opportunities, aligning with the Dubai Economic Agenda (D33) to boost market liquidity and foreign investment. In Q1 2026, DFM reported a 48% year-on-year increase in trading value, with foreign investors making up 54% of the trading activity.

- Dubai Financial Market (DFM) participated in the HSBC Global Investment Summit in Hong Kong to enhance international investor engagement, attracting significant interest from Asian institutional investors.  
- Discussions during the summit emphasized market access, sector opportunities, and Dubai’s strategic position in global capital flows, aligning with DFM’s goal to become a leading financial center.  
- In Q1 2026, total trading on DFM reached AED 61 billion, marking a 48% year-on-year increase, with foreign investors contributing to 54% of trading activity.

Zawya

HSBC 5xShortSG241213

ZAWYA: Dubai Financial Market’s Hong Kong visit drives strong investor engagement at HSBC Global Investment Summit 2026

HSBC executives, including CEO Georges Elhedery, are evaluating the impact of disruptions at the Strait of Hormuz and the Iran conflict on global energy markets and trade flows. The bank is focusing on risk management, client activity, and market volatility, particularly in relation to energy prices and shipping routes. Investors are advised to consider how geopolitical shocks influence HSBC's operations and risk strategies. The commentary highlights potential risks in Asia and the Middle East, while also noting increased demand for risk management solutions amid ongoing tensions.

- HSBC executives, including CEO Georges Elhedery, are evaluating the impact of disruptions at the Strait of Hormuz and the Iran conflict on global energy markets and trade flows.  
- The bank is closely linked to shifts in energy prices and hedge demand, providing insights into its risk management and client activity during geopolitical tensions.  
- Investors are advised to consider these factors when assessing HSBC's operations and potential volatility amidst ongoing risks in its primary markets across Asia, Europe, and the Middle East.

Simplywall

Standard Chartered PLC

JPMorgan Chase

Citigroup

STANCHART

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

CITIGROUP INC 6.250 NON CUM SER II PFD WI

HSBC Weighs Strait Of Hormuz Shock And Iran Conflict For Investors

As in vivo cell therapies enter clinical trials, suppliers are addressing technical and logistical challenges to ensure commercial viability. Recent acquisitions by major pharmaceutical companies, such as AstraZeneca's $1bn purchase of EsoBiotec, highlight growing interest in this field. In vivo therapies, which deliver genes directly to patients, are still in early development stages, with most players in preclinical or Phase I trials. The next year is crucial for gathering more data on these therapies, which are often misclassified as traditional cell therapies but are more akin to gene therapies.

Pharmaceutical Technology

AstraZeneca PLC

AstraZeneca

Alaunos Therapeutics

Eli Lilly

Abbvie

Bristol Myers Squibb

Lonza

Bristol-Myers Squibb Company

The innovators working to make in vivo cell therapy a reality

HSBC is considering selling its retail banking business in Indonesia, with OCBC Bank becoming the preferred buyer, and the transaction is expected to be valued at over IDR 60 trillion (approximately USD 350 million). Although OCBC Bank is leading in the bidding, negotiations are still ongoing, and a final agreement has not yet been reached, with the possibility of other bidders emerging. HSBC has approximately 2,300 employees and 28 branches in Indonesia

- HSBC's retail banking operations in Indonesia are reportedly up for acquisition, with OCBC Bank emerging as the front-runner.  
- If successful, the deal could value HSBC's personal banking business in Indonesia at over 60 trillion Indonesian rupiah (approximately 3.5 billion USD).  
- Negotiations are ongoing, and while no final decision has been made, other bidders may still enter the race.

香港 01

OCBC Bank

HSBC plans to sell its retail banking business in Indonesia, Bloomberg: OCBC Bank becomes the preferred buyer

OCBC Bank has become HSBC's preferred bidder for its retail banking business in Indonesia, with an acquisition valuation exceeding IDR 600 trillion (approximately SGD 445 million). OCBC Bank aims to expand its influence in the Indonesian market through this acquisition, and its bid is currently higher than that of other bidders. However, the final outcome is still uncertain, with other bidders including DBS Group, UOB, CIMB Group, and Sumitomo Mitsui Financial Group. HSBC has not yet made a final decision

- OCBC Bank aims to acquire HSBC's retail banking operations in Indonesia, with asset valuations potentially exceeding 60 trillion Indonesian rupiah (approximately 445 million SGD).  
- According to Bloomberg, OCBC has emerged as the preferred bidder but discussions remain ongoing, with no final decision made, and other bidders include DBS, UOB, CIMB Group, and Sumitomo Mitsui Financial Group.  
- If successful, this acquisition would be the first for OCBC's president, who seeks to expand the bank's presence in Asia while adopting more technology and supporting clients in transitioning to net-zero emissions.

Zaobao

Sumitomo Mitsui Financial Group, Inc.

Sumitomo Mitsui Financial

ANT GROUP

United Overseas Bank (UOB)

News: OCBC Bank becomes the preferred bidder for HSBC Indonesia assets | Lianhe Zaobao

Reuters

OCBC Is Said To Emerge As Lead Bidder For HSBC Indonesia Assets - Bloomberg News

Nestle India is expected to report revenue growth of 13-18% in Q4FY26, driven by single-digit domestic volume expansion. However, margins may face pressure due to rising input costs and geopolitical uncertainties. The board meeting on April 21 will approve financial statements and consider a final dividend for FY26. Brokerages predict varying revenue growth estimates, with Systematix forecasting ₹6,259 crore, Axis Securities at ₹6,445 crore, and Nirmal Bang at ₹5,950 crore. Operating margins are expected to contract year-on-year but may improve quarter-on-quarter due to raw material inflation trends.

Business Standard

ICICI Bank

HDFC Bank

Nestle India Q4 result preview: Revenue may grow 13-18%; margins could fall

00175

00001

The Hong Kong stock ADR is expected to open 179 points lower this morning, at 26,215 points. The relative stock prices of several stocks and the premium of Hong Kong stocks over American Depositary Receipts (ADRs) are also listed, including CKH HOLDINGS, HSBC HOLDINGS, and GEELY AUTO

AASTOCKS

GEELY AUTO

CKH HOLDINGS

The Hong Kong stock ADR is expected to open 179 points lower this morning, reporting at 26,215 points

02888

The People's Bank of China and the State Administration of Foreign Exchange jointly issued a notice to raise the overseas loan leverage ratio for foreign-funded legal person banks and foreign bank branches in China from 0.5 to 1.5, and the leverage ratio for the Export-Import Bank from 3 to 3.5. This move is expected to increase the overseas loan quota by 700 billion to 800 billion yuan, with major beneficiaries including the Export-Import Bank and large foreign banks such as UBS, HSBC, and STANCHART

- The People's Bank of China and the State Administration of Foreign Exchange have adjusted overseas loan policies for banks, increasing leverage ratios and setting new loan thresholds.  
- This change is anticipated to boost overseas loan limits by 700 billion to 800 billion yuan, benefiting banks like the Export-Import Bank and large foreign banks operating in China.  
- Analysts view this policy as a dual effort to enhance the internationalization of the renminbi while supporting domestic enterprises in cross-border financing, particularly amid rising demand for cross-border loans.

腾讯新闻 - 财经

The central bank and the foreign exchange bureau jointly raised the offshore loan leverage ratio for banks. Who benefits the most?

SPDW

Vanguard has launched two low-cost international equity ETFs: the Vanguard Developed Markets ex-US Value Index ETF (VDV) and the Vanguard Developed Markets ex-US Growth Index ETF (VDG). These funds provide targeted exposure to developed markets outside the U.S. with an expense ratio of 0.08%. The ETFs aim to offer investors flexibility in global allocations and serve as a passive alternative in a market dominated by active strategies. The launch comes as international ETFs have seen significant inflows, indicating a shift towards systematic investment approaches.

benzinga_article

The Vanguard Group, Inc.

VG FTSE Developed Markets ETF

VG Em Mkts

Vanguard Launches Low-Cost International ETFs Targeting Value, Growth Exposure

Unwell, Alex Cooper's media company, has appointed Joanne Bradford as president to lead its expanded executive team aimed at driving growth. Bradford, a strategic adviser since June 2025, will oversee operations and strategic growth, including partnerships with major brands like Google and Nestlé. The executive team also includes Mina Lefevre and T.J. Marchetti. Cooper emphasized the company's mission to cater to Gen Z women, while also addressing a public feud with Alix Earle.

Variety

Alphabet

Alphabet - C

Paypal

SoFi Tech

Pinterest

Microsoft

Meta Platforms

Disney

Netflix

Fox Corp -B

Alex Cooper’s Unwell Hires Joanne Bradford as President to Lead Expanded Executive Team

Pursuit Wealth Management LLC acquired a new stake in Astrazeneca Plc, purchasing 6,917 shares valued at approximately $636,000 during the 4th quarter. Other institutional investors also increased their stakes, with Brighton Jones LLC raising its holdings by 93.2%. Analysts have mixed ratings on Astrazeneca, with eight giving a Buy rating and one a Sell rating. The stock opened at $201.14, with a market cap of $311.95 billion. Astrazeneca recently announced a dividend of $1.595 per share, reflecting a yield of 156.0%.

Market Beat

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

iShares US Pharma

ALPS Medical Breakthrough

VanEck Biotech ETF

iShares Global Healthcare

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

VG Health

Direxion S&P Biotech Bull 3X

AstraZeneca PLC ADRhedged

iShares Biotechnology ETF

Pursuit Wealth Management LLC Takes Position in Astrazeneca Plc $AZN

RHHBY

RHHVF

Roche

ROCHE HOLDINGS AG

Sarepta Therap

Roche launches new Elevidys study after feedback from European regulator

SPDR World Ex Us(SPDW.US)

SPDR World Ex Us Stock Performance Chart

10:55 ETTEAMSTERS STATEMENT ON NESTLÉ'S ANTI-WORKER AGENDA

HSBC says Q1 earnings remain resilient despite turbulent markets

ZAWYA: Dubai Financial Market’s Hong Kong visit drives strong investor engagement at HSBC Global Investment Summit 2026

HSBC Weighs Strait Of Hormuz Shock And Iran Conflict For Investors

The innovators working to make in vivo cell therapy a reality